Original Article

Cell Research (2007) 17:389–401. doi: 10.1038/cr.2007.5; published online 27 February 2007

Receptor tyrosine kinases positively regulate BACE activity and Amyloid-bold beta production through enhancing BACE internalization

Lin Zou1,2,*, Zhu Wang1,*, Li Shen1,3, Guo Bin Bao1, Tian Wang1, Jiu Hong Kang1 and Gang Pei1

  1. 1Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
  2. 2Clinical Molecular Medical Center, Children's Hospital, Chongqing University of Medical Sicences, Chongqing 400011, China
  3. 3Graduate School of the Chinese Academy of Sciences, Shanghai 200031, China

Correspondence: Gang Pei, Tel: 86-21-5492-1371; Fax: 86-21-5492-1011; E-mail: gpei@sibs.ac.cn

*These authors contributed equally to this work

Received 16 December 2006; Revised 15 January 2007; Accepted 16 January 2007.

Top

Abstract

Amyloid-beta (Abeta) peptide, the primary constituent of senile plaques in Alzheimer's disease (AD), is generated by beta-secretase- and gamma-secretase-mediated sequential proteolysis of the amyloid precursor protein (APP). The aspartic protease, beta -site APP cleavage enzyme (BACE), has been identified as the main beta-secretase in brain but the regulation of its activity is largely unclear. Here, we demonstrate that both BACE activity and subsequent Abeta production are enhanced after stimulation of receptor tyrosine kinases (RTKs), such as the receptors for epidermal growth factor (EGF) and nerve growth factor (NGF), in cultured cells as well as in mouse hippocampus. Furthermore, stimulation of RTKs also induces BACE internalization into endosomes and Golgi apparatus. This enhancement of BACE activity and Abeta production upon RTK activation could be specifically inhibited by Src family kinase inhibitors and by depletion of endogenous c-Src with RNAi, and could be mimicked by over-expressed c-Src. Moreover, blockage of BACE internalization by a dominant negative form of Rab5 also abolished the enhancement of BACE activity and Abeta production, indicating the requirement of BACE internalization for the enhanced activity. Taken together, our study presents evidence that BACE activity and Abeta production are under the regulation of RTKs and this is achieved via RTK-stimulated BACE internalization, and suggests that an aberration of such regulation might contribute to pathogenic Abeta production.

Keywords:

beta-site APP cleavage enzyme, RTK, Amyloid-beta, Src

Abbreviations:

AD, (Alzheimer's disease); Abeta, (Amyloid-beta peptide); APP, (amyloid precursor protein); BACE, (beta-site APP cleavage enzyme); RTKs, (receptor tyrosine kinases); EGF, (epidermal growth factor); NGF, (nerve growth factor); EEA-1, (early endosome antigen-1); LAMP-1, (lysosomal-associated membrane protein); HEK 293, (human embryonic kidney 293); PP2, (4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine); PP3, (4-Amino-7-phenylpyrazol [3,4-d] pyrimidine); MAPK, (MAP Kinase); PI3K, (Phosphatidyl 3-Kinase); AEBSF, (4-(2-Aminoethyl) benzenesulfonylfluoride); ELISA, (Enzyme-linked Immunosorbent Assay); NS-RNAi, (non-specific RNA interference); GSK3beta, (glycogen synthase kinase 3beta)

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Alzheimer's disease A firm base for drug development

Nature News and Views (02 Dec 1999)

Alzheimer disease: BACE1 branches out

Nature Medicine News and Views (01 Oct 2006)

See all 3 matches for News And Views

Extra navigation

.

naturejobs

ADVERTISEMENT